Johnson & Johnson
Recent News About Johnson & Johnson
-
New talc front for Johnson & Johnson: Shareholder lawsuits
TRENTON, New Jersey — A Johnson & Johnson shareholder is claiming its board and officers schemed to defraud investors by concealing information about the company’s talc and baby powder. -
Judge in landmark $8 billion Risperdal case cuts punitive damages award down to $6.8 million
PHILADELPHIA – After a Philadelphia jury rendered a staggering $8 billion punitive damages verdict at the end of a recent trial surrounding anti-psychotic drug Risperdal in October, the judge who presided over the trial reduced the verdict to $6.8 million on Friday. -
Oklahoma asks for a half-million in costs after opioid trial against Johnson & Johnson
NORMAN, Okla. (Legal Newsline) – The state of Oklahoma is asking the Cleveland County District Court to levy nearly a half-million dollars against pharmaceutical giant Johnson & Johnson for court costs after winning a $465 million victory over the company in August for allegedly causing the state’s opioid crisis. -
New Mexico AG files talcum powder lawsuit as Johnson & Johnson racks up trial wins
SANTA FE, N.M. (Legal Newsline) - New Mexico Attorney General Hector Balderas has sued Johnson & Johnson for failing to warn consumers about asbestos in its iconic Baby Powder even as J&J is on a winning streak convincing judges and juries that the central allegation in the state’s case is untrue. -
St. Louis jury clears J&J in woman's ovarian cancer lawsuit
ST. LOUIS - A jury on Friday decided that Johnson & Johnson was not responsible for development of a St. Louis woman’s stage-two ovarian cancer from the use of its baby powder, which the plaintiff alleged had been contaminated with asbestos. -
Jury decides woman’s mesothelioma not a result of J&J baby powder
LOS ANGELES – A 12-member jury on Monday decided Johnson & Johnson was not responsible for Amy Fong’s mesothelioma, rejecting a lawsuit in which it was alleged baby powder Fong had breathed in Hong Kong during the 1970’s caused her to contract the deadly lung disease. -
Philadelphia now the top-ranked 'Judicial Hellhole'; Massive verdicts, like $8B Risperdal case, cited
WASHINGTON – In an annual report of “Judicial Hellholes” released today by the American Tort Reform Association, Philadelphia has claimed the No. 1 ranking – in part due to a historic $8 billion punitive damages verdict rendered this year in litigation connected to Johnson & Johnson’s anti-psychotic drug Risperdal. -
More bad news from Pa. court for J&J as it fights Risperdal lawsuits
PHILADELPHIA – The Superior Court of Pennsylvania has both upheld a $70 million compensatory damages award given to a Tennessee plaintiff in a case tied to the anti-psychotic drug Risperdal, and set the stage for another fight on punitive damages against Johnson & Johnson – which recently yielded a historic $8 billion verdict in a Philadelphia courtroom, in another action. -
Oklahoma wanted decades of funding from opioid verdict, but will get only one year's worth
NORMAN, Okla. (Legal Newsline) – Oklahoma’s landmark verdict in its opioid case against Johnson & Johnson does not mean the company must pump billions of dollars into the state over the next 30 years, a judge ruled Friday. -
Somewhere, Tim Robbins is laughing at Philadelphia
"That’s like saying, ‘I want gajillion bajillion dollars!’” -
'Wholly inadequate': Lawyers seek more opioid money by avoiding global settlement process
A proposed “negotiation class” to settle all opioid litigation by U.S. cities and counties could be in deep trouble, as the U.S. Court of Appeals for the Sixth Circuit considers an appeal of the order creating the controversial class and lawyers in two states with big claims urge their clients to opt out before a Nov. 22 deadline. -
New York scores January trial date for its opioid lawsuit
A New York judge has scheduled a Jan. 20 trial for opioid lawsuits by New York State and two counties, setting a short timeline for the companies to settle or face potentially crippling liability. -
Class action says opioid crisis caused insurance costs to increase, but N.J. court not buying it
TRENTON, N.J. (Legal Newsline) – On Oct. 10, a lawsuit against Johnson & Johnson, Janssen Pharmaceuticals Inc. and Actavis Pharma Inc. was dismissed by the Superior Court of New Jersey’s Law Division in Camden County as the plaintiff failed to prove the opioid crisis was the reason his insurance premium increased. -
Plaintiffs lawyers welcome judges from litigation hotbeds to conference in Las Vegas
LAS VEGAS (Legal Newsline) – Two judges involved in two of the most high-profile series of legal actions in the country were panelists at a Las Vegas conference organized by plaintiff lawyers. -
Oklahoma judge admits to $100M mistake in landmark opioid verdict against J&J
NORMAN, Okla. (Legal Newsline) – In a hearing Tuesday to clarify disagreements over a $572 million judgment against Johnson & Johnson for allegedly helping create an opioid epidemic in Oklahoma, attorneys for the state argued more money was needed to fully abate the problem, while lawyers for J&J requested joint liability credits to ease its burden. -
Breaking: In first test, Philadelphia jury punishes J&J with $8 billion verdict; Thousands more cases remain
PHILADELPHIA – In an unprecedented conclusion to the first-ever punitive damages trial tied to Risperdal, a 12-person jury found Johnson & Johnson and its subsidiary Janssen Pharmaceuticals liable for allegedly knowing and consciously disregarding the potential of the drug to cause gynecomastia to patients like plaintiff Nicholas Murray, and rendered a staggering verdict of $8 billion. -
Issues, like bias claims against judge, remain unresolved as bellwether opioid trials approach
CLEVELAND (Legal Newsline) - The remaining defendants facing an Oct. 21 trial in Ohio over opioid claims have asked the U.S. Court of Appeals for the Sixth Circuit to stay proceedings until challenges by the Ohio attorney general and others are concluded. -
Two recent talc verdicts went against J&J; Both sides vow to keep fighting
LOS ANGELES (Legal Newsline) – Officials for Johnson & Johnson and attorneys representing plaintiffs suing the company for alleged asbestos-tainted baby powder both vowed on Tuesday to continue litigating after two recent verdicts went against the company. -
'Absolute panic' as cities, counties face deadline on opioid 'negotiation class'
CLEVELAND (Legal Newsline) - Cities and counties are worried and confused as they face a November deadline to join or opt out of an unprecedented “negotiation class” that could determine how much money they get from opioid litigation, a lawyer who represents Texas municipalities said. -
Companies blamed for addiction crisis attack plaintiffs' case before historic opioid trial
CLEVELAND (Legal Newsline) - Opioid manufacturers and distributors attacked the fundamental allegations in lawsuits by two Ohio counties that are scheduled to begin trial next month, saying they didn’t contribute to the “public nuisance” of opioid abuse and violated no laws by selling their products in Ohio.